Jane Wang
Chief Tech/Sci/R&D Officer at APOLLOMICS, INC.
Profile
Jane Wang currently works at Apollomics, Inc. (United States), as Chief Scientific Officer and Apollomics, Inc., as Chief Scientific Officer from 2023.
Dr. Wang also formerly worked at Pfizer Inc., as Principal and WuXi AppTec Co., Ltd., as Vice President-Medicinal Chemistry from 2010 to 2022.
Dr. Wang received her doctorate degree from the University of Maryland and undergraduate degree from Fudan University.
Jane Wang active positions
| Companies | Position | Start |
|---|---|---|
| APOLLOMICS, INC. | Chief Tech/Sci/R&D Officer | 2023-03-29 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Chief Tech/Sci/R&D Officer | - |
Former positions of Jane Wang
| Companies | Position | End |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 2022-06-30 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Jane Wang
| Fudan University | Undergraduate Degree |
| University of Maryland | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| APOLLOMICS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
- Stock Market
- Insiders
- Jane Wang
